Article
[Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].
Zhongguo shi yan xue ye xue za zhi - 1 Dec 2020
Zhang Yu, Liu Ruo-Yang, Wang Shu-Juan, Wang Chong, Zhang Qiu-Tang, He Chen, Xie Xin-Sheng, Wan Ding-Ming, Jiang Zhong-Xing, Liu Yan-Fang
Abstract excerpt
OBJECTIVE: To investigate the expression of CD123 in patients with acute myeloid leukemia (AML) and its relationship between clinical features, concomitant fusion gene or gene mutation, efficacy and prognosis. METHODS: 365 patients with newly diagnosed AML (except M3) treated in the First Affiliated Hospital of Zhengzhou University were enrolled and retrospective analysis, and multi-parameter flow cytometry was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
